![](/img/cover-not-exists.png)
Cost-Effectiveness Analysis of Exenatide Once-Weekly Versus Dulaglutide, Liraglutide and Lixisenatide for the Treatment of Type 2 Diabetes Mellitus: An Analysis from the UK NHS Perspective
Charokopou, M, Chuang, L, Verheggen, B, Gibson, D, Grandy, S, Kartman, BVolume:
18
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2015.09.2090
Date:
November, 2015
File:
PDF, 52 KB
english, 2015